Eli Lilly, Sanofi Agree To $35 A Month Insulin Price Cap In New York Settlements
NEW YORK — Drugmakers Eli Lilly & Co. and Sanofi-Aventis US LLC have signed settlement agreements with the New York attorney general to cap the price of insulin for diabetics at...To view the full article, register now.
Already a subscriber? Click here to view full article